Related Experiment Video
Updated: Dec 29, 2025

06:46
Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
671
Sudden Unexplained Death - Treating the Family.
1Clinical Research Fellow & Specialist Registrar Cardiology.
Arrhythmia & Electrophysiology Review
|February 3, 2016
Summary
Sudden arrhythmic death syndrome (SADS) is often caused by inherited heart conditions. Genetic testing and family screening are crucial for diagnosing SADS and preventing future deaths.
Area of Science:
- Cardiology
- Genetics
- Forensic Pathology
Background:
- Sudden unexplained death with a normal post-mortem heart and toxicology is Sudden Arrhythmic Death Syndrome (SADS).
- SADS is frequently linked to inherited cardiac conditions, especially channelopathies.
- Family screening of SADS victims often identifies affected individuals in up to 50% of cases.
Purpose of the Study:
- To outline the diagnostic approach for Sudden Arrhythmic Death Syndrome (SADS).
- To emphasize the importance of expert cardiac autopsy and molecular autopsy in SADS diagnosis.
- To detail the clinical evaluation and management strategies for families affected by SADS.
Main Methods:
- Expert cardiac autopsy to ensure diagnostic accuracy.
- 'Molecular autopsy' involving post-mortem genetic testing.
- Clinical assessment including ECG, echocardiogram, exercise testing, and provocation tests (sodium channel blocker, epinephrine).
Main Results:
- Expert autopsy improves diagnostic accuracy in SADS cases.
- Molecular autopsy can provide a genetic diagnosis in up to one-third of SADS cases.
- Family screening reveals affected individuals in a significant proportion of SADS victims.
Conclusions:
- A systematic approach combining autopsy, genetic testing, and clinical evaluation is essential for SADS.
- Early diagnosis and management of SADS families, guided by established protocols, can prevent further deaths.
- Negative investigations may allow patient discharge, with exceptions for young or symptomatic individuals.
Keywords:
Sudden deathexercise testfamily assessmentmolecular autopsypost-mortemsudden arrhythmic death syndromeMore Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
304
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
304
Acute Coronary Syndrome IV: Interprofessional Care
174
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
174
Coronary Artery Disease III: Clinical Manifestations
251
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
251
Acute Coronary Syndrome I: Introduction
611
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
611
Anticholinesterase Agents: Poisoning and Treatment
1.4K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.4K
Electroconvulsive Therapy
677
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
677

